Eyeing for JNJ stock? Know why J&J is splitting into 2 companies

Healthcare company Johnson & Johnson (NYSE: JNJ) announced on Friday to split the business into two companies in the next two years, triggering a...

AstraZeneca (AZN) revenue skyrockets; is the stock worth exploring?

Highlights AstraZeneca PLC (NASDAQ: AZN) revenue increased 50% YoY to US$9.877 billion in the third quarter ended September 30, 2021. However...

Is RenovoRx (RNXT) stock worth exploring? Know more.

Highlights RenovoRx, Inc. (NASDAQ: RNXT) stock jumped over 66% in premarket on Wednesday. The company had made a presentation on its therapeutic p...

CVS (CVS), Humana (HUM) revise guidance after strong Q3 results

Highlights CVS Health Corporation (NYSE: CVS) revenue rose 10% YoY to US$73.8 in Q3. Humana Inc. (NYSE: HUM) revenue rose 3% to US$20.7 billion i...

Pfizer (PFE) raises guidance after Q3 revenue jumps 134%

Highlights Pfizer, Inc. (NYSE: PFE) revenue increased by 134% YoY to US$24.1 billion in Q3. The company raised guidance for fiscal 2021 after robu...

Why did ABVC stock jump more than 200% today?

ABVC Biopharma, Inc. (NASDAQ: ABVC) jumped more than 219% on Monday after receiving approval from Taiwan Central Institutional Review Board to st...

AbbVie (ABBV) raises full-year guidance after Q3 revenue boost

Highlights AbbVie Inc. (NYSE: ABBV) posted third-quarter revenue of US$14.342 billion, up 11.2% YoY. It raised the GAAP diluted EPS guidance to a...

Merck (MRK), Sanofi (SNY) raise profit guidance after solid Q3 resul...

Highlights Merck & Company, Inc’s (MRK) sales rose 20% YoY in Q3, FY21. Merck expects its adjusted annual profit to be between US$5.65 p...

Bristol Myers (BMY), GlaxoSmithKline (GSK) post strong revenue growt...

Highlights Bristol-Myers Squibb Company (NYSE: BMY) revenue surged 10% YoY to US$11.5 billion in Q3, FY21. BMY raised its low-end adjusted EPS gui...

Thermo Fisher (TMO), Boston Scientific (BSX) lift guidance after Q3...

Highlights Thermo Fisher Scientific Inc’s (NYSE: TMO) revenue increased by 9% YoY in Q3, FY21. TMO raised its revenue guidance for fiscal 20...

Eli Lilly (LLY), Novartis (NVS) profits up on robust sales growth

Highlights Eli Lilly and Company (NYSE: LLY) posted Q3 revenue of US$6.773 billion, up 18% YoY. Novartis AG’s (NYSE: NVS) net income rose 43...

Abbott (ABT), Anthem (ANTM) stocks rise after upbeat revenue outlook

Highlights Abbott Laboratories’ (NYSE: ABT) third-quarter sales rose 23.4% to US$10.9 billion YoY. Abbott raised its full-year adjusted EPS...

PROG, ADMP stocks jump after FDA approval, patent rights

Highlights Progenity, Inc. (NASDAQ: PROG) secured four patents for ingestible technologies from the US Patent and Trademark Office (USPTO). The P...

Seven stocks to explore as demand for healthcare soars

Highlights  CVS Health Corporation’s (NYSE: CVS) next ex-dividend date is Oct 21, 2021. Global Cord Blood Corporation’s (NYSE...

Why is the stock of gene-editing titan CRISPR hogging attention?

Swiss-American biotechnology company CRISPR Therapeutics (NASDAQ: CRSP) has been gaining significant attention in recent days. While the stock has see...

Walgreens Boots (WBA) profits up 6.4% in Q4 as sales surge

Pharmacy chain operator Walgreens Boots Alliance Reports on Thursday reported a fourth-quarter profit of US$358 million after witnessing robust growth...

UnitedHealth (UNH) raises guidance on strong Q3 growth, revenue up 1...

Highlights UnitedHealth Group (NYSE: UNH) declared third-quarter results on Thursday. The group served 146 million people across its businesses as...

Nutriband (NTRB), Protara (TARA) stocks gallop on deals, drug approv...

Highlights Nutriband Inc. (NASDAQ: NTRB) stock jumped on securing a lucrative manufacturing deal with San Diego-based Diomics for its Diocheck&trad...

CLOV, ADMS stocks up on rating upgrade, purchase deal

Highlights Stocks of Clover Health Investments, Corp. (NASDAQ: CLOV) and Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) were gaining traction on Monda...

ChemoCentryx (CCXI), Vaxart (VXRT) stocks rally on upbeat drug news

Highlights FDA has approved ChemoCentryx's drug Avacopan, to be sold under the brand name Tavneos. A Duke University study showed Vaxart's oral dr...